Global Terbinafine (Lamisil) Market Research Report 2022

Global Terbinafine (Lamisil) Market Research Report 2022

Table of Contents
1 Terbinafine (Lamisil) Market Overview
1.1 Product Overview and Scope of Terbinafine (Lamisil)
1.2 Terbinafine (Lamisil) Segment by Type
1.2.1 Global Terbinafine (Lamisil) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral
1.2.3 External Use
1.3 Terbinafine (Lamisil) Segment by Application
1.3.1 Global Terbinafine (Lamisil) Sales Comparison by Application: (2022-2028)
1.3.2 Fungal Infection Of The Skin And Mucous Membrane
1.3.3 Onychomycosis
1.3.4 Bronchial Asthma
1.3.5 Gynecological Anti-Infection Preparation
1.3.6 Other
1.4 Global Terbinafine (Lamisil) Market Size Estimates and Forecasts
1.4.1 Global Terbinafine (Lamisil) Revenue 2017-2028
1.4.2 Global Terbinafine (Lamisil) Sales 2017-2028
1.4.3 Terbinafine (Lamisil) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Terbinafine (Lamisil) Market Competition by Manufacturers
2.1 Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Terbinafine (Lamisil) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Terbinafine (Lamisil) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Terbinafine (Lamisil) Manufacturing Sites, Area Served, Product Type
2.5 Terbinafine (Lamisil) Market Competitive Situation and Trends
2.5.1 Terbinafine (Lamisil) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Terbinafine (Lamisil) Players Market Share by Revenue
2.5.3 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terbinafine (Lamisil) Retrospective Market Scenario by Region
3.1 Global Terbinafine (Lamisil) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Terbinafine (Lamisil) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Terbinafine (Lamisil) Market Facts & Figures by Country
3.3.1 North America Terbinafine (Lamisil) Sales by Country
3.3.2 North America Terbinafine (Lamisil) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Terbinafine (Lamisil) Market Facts & Figures by Country
3.4.1 Europe Terbinafine (Lamisil) Sales by Country
3.4.2 Europe Terbinafine (Lamisil) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Terbinafine (Lamisil) Market Facts & Figures by Region
3.5.1 Asia Pacific Terbinafine (Lamisil) Sales by Region
3.5.2 Asia Pacific Terbinafine (Lamisil) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Terbinafine (Lamisil) Market Facts & Figures by Country
3.6.1 Latin America Terbinafine (Lamisil) Sales by Country
3.6.2 Latin America Terbinafine (Lamisil) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Terbinafine (Lamisil) Market Facts & Figures by Country
3.7.1 Middle East and Africa Terbinafine (Lamisil) Sales by Country
3.7.2 Middle East and Africa Terbinafine (Lamisil) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Terbinafine (Lamisil) Historic Market Analysis by Type
4.1 Global Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
4.2 Global Terbinafine (Lamisil) Revenue Market Share by Type (2017-2022)
4.3 Global Terbinafine (Lamisil) Price by Type (2017-2022)
5 Global Terbinafine (Lamisil) Historic Market Analysis by Application
5.1 Global Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
5.2 Global Terbinafine (Lamisil) Revenue Market Share by Application (2017-2022)
5.3 Global Terbinafine (Lamisil) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Corporation Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Perrigo Terbinafine (Lamisil) Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Novartis Pharmaceuticals Corporation
6.2.1 Novartis Pharmaceuticals Corporation Corporation Information
6.2.2 Novartis Pharmaceuticals Corporation Description and Business Overview
6.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolio
6.2.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
6.3 Gokul Pharma
6.3.1 Gokul Pharma Corporation Information
6.3.2 Gokul Pharma Description and Business Overview
6.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Gokul Pharma Terbinafine (Lamisil) Product Portfolio
6.3.5 Gokul Pharma Recent Developments/Updates
6.4 TEVA
6.4.1 TEVA Corporation Information
6.4.2 TEVA Description and Business Overview
6.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 TEVA Terbinafine (Lamisil) Product Portfolio
6.4.5 TEVA Recent Developments/Updates
6.5 Mylan Pharmaceuticals
6.5.1 Mylan Pharmaceuticals Corporation Information
6.5.2 Mylan Pharmaceuticals Description and Business Overview
6.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.5.5 Mylan Pharmaceuticals Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Pfizer Terbinafine (Lamisil) Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sivem Pharmaceuticals
6.6.1 Sivem Pharmaceuticals Corporation Information
6.6.2 Sivem Pharmaceuticals Description and Business Overview
6.6.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.7.5 Sivem Pharmaceuticals Recent Developments/Updates
6.8 Apotex Corporation
6.8.1 Apotex Corporation Corporation Information
6.8.2 Apotex Corporation Description and Business Overview
6.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Apotex Corporation Terbinafine (Lamisil) Product Portfolio
6.8.5 Apotex Corporation Recent Developments/Updates
6.9 Auro Pharma Inc
6.9.1 Auro Pharma Inc Corporation Information
6.9.2 Auro Pharma Inc Description and Business Overview
6.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Auro Pharma Inc Terbinafine (Lamisil) Product Portfolio
6.9.5 Auro Pharma Inc Recent Developments/Updates
6.10 PLIVA
6.10.1 PLIVA Corporation Information
6.10.2 PLIVA Description and Business Overview
6.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 PLIVA Terbinafine (Lamisil) Product Portfolio
6.10.5 PLIVA Recent Developments/Updates
6.11 Jamp Pharma Corporation
6.11.1 Jamp Pharma Corporation Corporation Information
6.11.2 Jamp Pharma Corporation Terbinafine (Lamisil) Description and Business Overview
6.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolio
6.11.5 Jamp Pharma Corporation Recent Developments/Updates
6.12 Nu Pharm
6.12.1 Nu Pharm Corporation Information
6.12.2 Nu Pharm Terbinafine (Lamisil) Description and Business Overview
6.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Nu Pharm Terbinafine (Lamisil) Product Portfolio
6.12.5 Nu Pharm Recent Developments/Updates
6.13 Codal Synto
6.13.1 Codal Synto Corporation Information
6.13.2 Codal Synto Terbinafine (Lamisil) Description and Business Overview
6.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Codal Synto Terbinafine (Lamisil) Product Portfolio
6.13.5 Codal Synto Recent Developments/Updates
6.14 Qd Pharmaceuticals
6.14.1 Qd Pharmaceuticals Corporation Information
6.14.2 Qd Pharmaceuticals Terbinafine (Lamisil) Description and Business Overview
6.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.14.5 Qd Pharmaceuticals Recent Developments/Updates
6.15 Pharmel Inc
6.15.1 Pharmel Inc Corporation Information
6.15.2 Pharmel Inc Terbinafine (Lamisil) Description and Business Overview
6.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Pharmel Inc Terbinafine (Lamisil) Product Portfolio
6.15.5 Pharmel Inc Recent Developments/Updates
6.16 Smaart Pharmaceutticals
6.16.1 Smaart Pharmaceutticals Corporation Information
6.16.2 Smaart Pharmaceutticals Terbinafine (Lamisil) Description and Business Overview
6.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolio
6.16.5 Smaart Pharmaceutticals Recent Developments/Updates
6.17 Qilu Pharmaceutical
6.17.1 Qilu Pharmaceutical Corporation Information
6.17.2 Qilu Pharmaceutical Terbinafine (Lamisil) Description and Business Overview
6.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolio
6.17.5 Qilu Pharmaceutical Recent Developments/Updates
6.18 Qingdao Jinfeng Pharmaceutical
6.18.1 Qingdao Jinfeng Pharmaceutical Corporation Information
6.18.2 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Description and Business Overview
6.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolio
6.18.5 Qingdao Jinfeng Pharmaceutical Recent Developments/Updates
7 Terbinafine (Lamisil) Manufacturing Cost Analysis
7.1 Terbinafine (Lamisil) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Terbinafine (Lamisil)
7.4 Terbinafine (Lamisil) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Terbinafine (Lamisil) Distributors List
8.3 Terbinafine (Lamisil) Customers
9 Terbinafine (Lamisil) Market Dynamics
9.1 Terbinafine (Lamisil) Industry Trends
9.2 Terbinafine (Lamisil) Market Drivers
9.3 Terbinafine (Lamisil) Market Challenges
9.4 Terbinafine (Lamisil) Market Restraints
10 Global Market Forecast
10.1 Terbinafine (Lamisil) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Terbinafine (Lamisil) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Terbinafine (Lamisil) by Type (2023-2028)
10.2 Terbinafine (Lamisil) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Terbinafine (Lamisil) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Terbinafine (Lamisil) by Application (2023-2028)
10.3 Terbinafine (Lamisil) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Terbinafine (Lamisil) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Terbinafine (Lamisil) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Terbinafine (Lamisil) Sales Growth Rate Comparison by Type (2022-2028) & (KG) & (US$ Million)
Table 2. Global Terbinafine (Lamisil) Sales Growth Rate Comparison by Application (2022-2028) & (KG) & (US$ Million)
Table 3. Global Terbinafine (Lamisil) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Terbinafine (Lamisil) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Terbinafine (Lamisil) Sales (KG) of Key Manufacturers (2017-2022)
Table 6. Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Terbinafine (Lamisil) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Terbinafine (Lamisil) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Terbinafine (Lamisil) Average Price (US$/G) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Terbinafine (Lamisil) Manufacturing Sites and Area Served
Table 11. Manufacturers Terbinafine (Lamisil) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Terbinafine (Lamisil) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Terbinafine (Lamisil) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Terbinafine (Lamisil) Sales by Region (2017-2022) & (KG)
Table 16. Global Terbinafine (Lamisil) Sales Market Share by Region (2017-2022)
Table 17. Global Terbinafine (Lamisil) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Terbinafine (Lamisil) Revenue Market Share by Region (2017-2022)
Table 19. North America Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 20. North America Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 21. North America Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 23. Europe Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 24. Europe Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 25. Europe Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Terbinafine (Lamisil) Sales by Region (2017-2022) & (KG)
Table 28. Asia Pacific Terbinafine (Lamisil) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Terbinafine (Lamisil) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 32. Latin America Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 33. Latin America Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Terbinafine (Lamisil) Sales by Country (2017-2022) & (KG)
Table 36. Middle East and Africa Terbinafine (Lamisil) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Terbinafine (Lamisil) Revenue Market Share by Country (2017-2022)
Table 39. Global Terbinafine (Lamisil) Sales by Type (2017-2022) & (KG)
Table 40. Global Terbinafine (Lamisil) Sales Market Share by Type (2017-2022)
Table 41. Global Terbinafine (Lamisil) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Terbinafine (Lamisil) Revenue Share by Type (2017-2022)
Table 43. Global Terbinafine (Lamisil) Price by Type (2017-2022) & (US$/G)
Table 44. Global Terbinafine (Lamisil) Sales (KG) by Application (2017-2022)
Table 45. Global Terbinafine (Lamisil) Sales Market Share by Application (2017-2022)
Table 46. Global Terbinafine (Lamisil) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Terbinafine (Lamisil) Revenue Share by Application (2017-2022)
Table 48. Global Terbinafine (Lamisil) Price by Application (2017-2022) & (US$/G)
Table 49. Perrigo Corporation Information
Table 50. Perrigo Description and Business Overview
Table 51. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 52. Perrigo Terbinafine (Lamisil) Product
Table 53. Perrigo Recent Developments/Updates
Table 54. Novartis Pharmaceuticals Corporation Corporation Information
Table 55. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 56. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 57. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product
Table 58. Novartis Pharmaceuticals Corporation Recent Developments/Updates
Table 59. Gokul Pharma Corporation Information
Table 60. Gokul Pharma Description and Business Overview
Table 61. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 62. Gokul Pharma Terbinafine (Lamisil) Product
Table 63. Gokul Pharma Recent Developments/Updates
Table 64. TEVA Corporation Information
Table 65. TEVA Description and Business Overview
Table 66. TEVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 67. TEVA Terbinafine (Lamisil) Product
Table 68. TEVA Recent Developments/Updates
Table 69. Mylan Pharmaceuticals Corporation Information
Table 70. Mylan Pharmaceuticals Description and Business Overview
Table 71. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 72. Mylan Pharmaceuticals Terbinafine (Lamisil) Product
Table 73. Mylan Pharmaceuticals Recent Developments/Updates
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 77. Pfizer Terbinafine (Lamisil) Product
Table 78. Pfizer Recent Developments/Updates
Table 79. Sivem Pharmaceuticals Corporation Information
Table 80. Sivem Pharmaceuticals Description and Business Overview
Table 81. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 82. Sivem Pharmaceuticals Terbinafine (Lamisil) Product
Table 83. Sivem Pharmaceuticals Recent Developments/Updates
Table 84. Apotex Corporation Corporation Information
Table 85. Apotex Corporation Description and Business Overview
Table 86. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 87. Apotex Corporation Terbinafine (Lamisil) Product
Table 88. Apotex Corporation Recent Developments/Updates
Table 89. Auro Pharma Inc Corporation Information
Table 90. Auro Pharma Inc Description and Business Overview
Table 91. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 92. Auro Pharma Inc Terbinafine (Lamisil) Product
Table 93. Auro Pharma Inc Recent Developments/Updates
Table 94. PLIVA Corporation Information
Table 95. PLIVA Description and Business Overview
Table 96. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 97. PLIVA Terbinafine (Lamisil) Product
Table 98. PLIVA Recent Developments/Updates
Table 99. Jamp Pharma Corporation Corporation Information
Table 100. Jamp Pharma Corporation Description and Business Overview
Table 101. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 102. Jamp Pharma Corporation Terbinafine (Lamisil) Product
Table 103. Jamp Pharma Corporation Recent Developments/Updates
Table 104. Nu Pharm Corporation Information
Table 105. Nu Pharm Description and Business Overview
Table 106. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 107. Nu Pharm Terbinafine (Lamisil) Product
Table 108. Nu Pharm Recent Developments/Updates
Table 109. Codal Synto Corporation Information
Table 110. Codal Synto Description and Business Overview
Table 111. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 112. Codal Synto Terbinafine (Lamisil) Product
Table 113. Codal Synto Recent Developments/Updates
Table 114. Qd Pharmaceuticals Corporation Information
Table 115. Qd Pharmaceuticals Description and Business Overview
Table 116. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 117. Qd Pharmaceuticals Terbinafine (Lamisil) Product
Table 118. Qd Pharmaceuticals Recent Developments/Updates
Table 119. Pharmel Inc Corporation Information
Table 120. Pharmel Inc Description and Business Overview
Table 121. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 122. Pharmel Inc Terbinafine (Lamisil) Product
Table 123. Pharmel Inc Recent Developments/Updates
Table 124. Smaart Pharmaceutticals Corporation Information
Table 125. Smaart Pharmaceutticals Description and Business Overview
Table 126. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 127. Smaart Pharmaceutticals Terbinafine (Lamisil) Product
Table 128. Smaart Pharmaceutticals Recent Developments/Updates
Table 129. Qilu Pharmaceutical Corporation Information
Table 130. Qilu Pharmaceutical Description and Business Overview
Table 131. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 132. Qilu Pharmaceutical Terbinafine (Lamisil) Product
Table 133. Qilu Pharmaceutical Recent Developments/Updates
Table 134. Qingdao Jinfeng Pharmaceutical Corporation Information
Table 135. Qingdao Jinfeng Pharmaceutical Description and Business Overview
Table 136. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 137. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product
Table 138. Qingdao Jinfeng Pharmaceutical Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Terbinafine (Lamisil) Distributors List
Table 142. Terbinafine (Lamisil) Customers List
Table 143. Terbinafine (Lamisil) Market Trends
Table 144. Terbinafine (Lamisil) Market Drivers
Table 145. Terbinafine (Lamisil) Market Challenges
Table 146. Terbinafine (Lamisil) Market Restraints
Table 147. Global Terbinafine (Lamisil) Sales Forecast by Type (2023-2028) & (KG)
Table 148. Global Terbinafine (Lamisil) Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Terbinafine (Lamisil) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Terbinafine (Lamisil) Sales Forecast by Application (2023-2028) & (KG)
Table 152. Global Terbinafine (Lamisil) Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Terbinafine (Lamisil) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Terbinafine (Lamisil) Sales Forecast by Region (2023-2028) & (KG)
Table 156. Global Terbinafine (Lamisil) Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Terbinafine (Lamisil) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Terbinafine (Lamisil) Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Terbinafine (Lamisil)
Figure 2. Global Terbinafine (Lamisil) Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. External Use Product Picture
Figure 5. Global Terbinafine (Lamisil) Market Share by Application in 2021 & 2028
Figure 6. Fungal Infection Of The Skin And Mucous Membrane
Figure 7. Onychomycosis
Figure 8. Bronchial Asthma
Figure 9. Gynecological Anti-Infection Preparation
Figure 10. Other
Figure 11. Global Terbinafine (Lamisil) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Terbinafine (Lamisil) Market Size (2017-2028) & (US$ Million)
Figure 13. Global Terbinafine (Lamisil) Sales (2017-2028) & (KG)
Figure 14. Terbinafine (Lamisil) Sales Share by Manufacturers in 2021
Figure 15. Global Terbinafine (Lamisil) Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Terbinafine (Lamisil) Players: Market Share by Revenue in 2021
Figure 17. Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Terbinafine (Lamisil) Sales Market Share by Region (2017-2022)
Figure 19. Global Terbinafine (Lamisil) Sales Market Share by Region in 2021
Figure 20. Global Terbinafine (Lamisil) Revenue Market Share by Region (2017-2022)
Figure 21. Global Terbinafine (Lamisil) Revenue Market Share by Region in 2021
Figure 22. U.S. Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. UAE Terbinafine (Lamisil) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Terbinafine (Lamisil) by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Terbinafine (Lamisil)
Figure 48. Manufacturing Process Analysis of Terbinafine (Lamisil)
Figure 49. Terbinafine (Lamisil) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs